In Staphylococcus aureus infection, intraspecies cross-inhibition mediated by the regulatory system agr may lead to the exclusion of heterologous strains at the site of infection or colonization. We analyzed consecutive and cocolonizing strains (classified as different clones by pulsed-field gel electrophoresis) from patients with cystic fibrosis (CF) and healthy individuals. Strain replacement was accompanied by a change in the agr group in 80% of the patients with CF and in 63% of the healthy individuals. Cocolonizing strains from patients with CF were shown to belong to interfering agr groups in 6 of 10 cases. In contrast, in healthy individuals, cocolonization of the nares with strains of interfering agr groups was rarely observed. agr polymorphism has no impact on the colonization dynamics of S. aureus in patients with CF but may influence nasal colonization in health individuals.
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The major human pathogen Staphylococcus aureus asymptomatically colonizes the anterior nares of humans but also causes a wide spectrum of diseases [1] . S. aureus infections are probably established via the coordinated synthesis of extracellular and cell-bound virulence factors [2] . The expression of most virulence factors is controlled by global regulators, such as agr. The agr locus, which consists of 5 genes (agrA, agrC, agrD, agrB, and hld), codes for 2 divergent transcripts (RNAII and RNAIII) initiated by 2 distinct promoters (P2 and P3). RNAIII is the effector molecule, exhibiting a positive regulatory effect on extracellular proteins, such as a-hemolysin, and a negative regulatory effect on protein A-and fibronectin-binding proteins [3] [4] [5] [6] . agrA shows sequence homology to the response regulator, whereas agrC corresponds to the histidine protein kinase signal transducer [7] of the classic 2-component inhibition of agr expression leads to the exclusion of heterologous strains at the site of colonization or infection. For this purpose, agr polymorphism in consecutive and cocolonizing S. aureus strains was assessed. We compared S. aureus isolates obtained from patients with chronic infection (lung infection in patients with cystic fibrosis [CF]) with isolates from nose colonization in healthy individuals in the community. The prevalence of agr group I-IV strains also was determined in intubated patients from an intensive care unit (ICU) and in patients with chronic wounds.
MATERIALS AND METHODS
Strain collection. S. aureus isolates were collected from 133 individuals: 35 nonhospitalized patients with CF (sputum samples), 30 intubated patients in an ICU (tracheal secretions), 31 patients from an out-patient wound consultation clinic (wound swabs), and 37 healthy control subjects (nose swabs). Patients with CF attended the CF center in Tübingen quarterly for regular check-ups. Antibiotics were prescribed according to the standard guidelines of the center. Patients in the ICU were admitted to this ward after major surgeries. All had received prophylactic antibiotic treatment. Tracheal secretions were obtained 2-5 days after intubation. The category of wound patients mainly consisted of patients with diabetes mellitus. In all but 2 cases, the S. aureus-positive wound swabs were not accompanied by inflammatory signs, and no antibiotic treatment was applied. The healthy individuals included family members from a study with CF and non-CF families [19] , family members and acquaintances of the laboratory staff, and pharmaceutical students attending courses at our institute. Informed consent was obtained from all subjects or their parents or guardians, and the human experimentation guidelines of the University of Tübingen were followed in the conduct of clinical research. S. aureus was isolated and identified from the different specimens by use of standard procedures. For the detection of mixed populations, primary plates (sheep blood agar plates) were inspected for the occurrence of phenotypic different colonies, which were processed separately. All isolates were typed by pulsed-field gel electrophoresis (PFGE), as described elsewhere [19] .
Identification of agr locus restriction fragment-length polymorphisms (RFLPs). For preparation of the template DNA for polymerase chain reaction (PCR), 1 mL of an overnight culture of S. aureus in tryptic-soy broth was pelleted and resuspended in 100 mL of TE buffer (10 mmol Tris-HCl and 1 mmol EDTA [pH 8]) containing 30 mg/mL recombinant lysostaphin (Ambi). The cells were lysed for 20 min at 37ЊC. Proteolysis was performed by adding 400 mL of proteolysis buffer (0.25 mol EDTA, 20 mmol EGTA, and 1% lauroylsarcosine [pH 9.0]) with 100 mg/mL proteinase K at 55ЊC for 1 h. Proteinase K was inactivated for 10 min at 95ЊC. PCR was done using 1:10 or 1:100 dilutions of DNA preparations in PCR-grade water. It was done in 50-mL volumes containing 2 mL of DNA template, 0.2 mmol dNTP mix, 2 mmol MgCl 2 , 2.5 U of HotStar Taq polymerase (Qiagen), and 10 pmol each of the forward and reverse primers. Primers were as described by Papakyriacou et al. [14] . After PCR, the 1884-bp amplicons were digested for 2-4 h with restriction enzyme DraI (Roche Biochemicals). The fragments were resolved by electrophoresis through 3% agarose and visualized by ethidium-bromide staining. RFLP patterns were assigned to the published agr groups by predicting the DraI restriction fragments of the respective GenBank sequences using the HUSAR software package (DKFZ). S. aureus RN6390 was used throughout the procedure to verify the results.
Cloning and sequence analysis of agr polymorphisms. To verify the assignment of RFLP patterns to specific agr groups, PCR amplicons were sent to an external laboratory for DNA sequencing (4base lab GmbH, Reutlingen, Germany). The sequences were aligned with the published agr sequences using the HUSAR software package (DKFZ).
agr Activation and inhibition assay in vitro. To test for cross-inhibition among S. aureus isolates of interfering agr groups, culture supernatants were prepared from strains grown to postexponential phase (OD 600 of 8) and sterile filtered. For test cultures, cells were inoculated from an overnight culture to an initial OD 600 of 0.05 in CYPG (1% casamino acid, 1% yeast extract, 0.5% glucose, 0.59% NaCl, and 60 mmol glycerophosphate) [20] and grown for 30 min at 37ЊC. One milliliter of the sterile filtered supernatant or 1 mL of CYPG as control was added to 9 mL of the culture, after which the bacteria were allowed to grow to an OD 600 of 0.6 (t1) or 2.5 (t2). RNA was prepared from these cells, as described elsewhere [21] . agr status was determined by detecting RNAIII transcription using Northern blot analysis, as described elsewhere [21] .
Statistical analysis. Comparison of the frequencies of agr interference groups in isolates from different patient categories to healthy individuals was done using the likelihood ratio test for contingency tables. Because this involves multiple testing, a adjustment was performed according to the Bonferroni method (P vs. the global significance level of 5% divided by the number of tests). To compare the frequency of identical agr groups in consecutive isolates from patients with CF with that in healthy control subjects, Fisher's exact test was applied.
RESULTS
Prevalence of agr interference groups in different categories of individuals. S. aureus isolates were obtained from healthy individuals of the community, patients with CF, intubated patients, and patients with chronic wounds. The isolates were [12] [13] [14] by sequence analysis of selected strains. Three patterns were observed only once each. Sequence analysis revealed that 2 patterns could be attributed to agr group I: in 1 case, the altered RFLP pattern could be explained by insertion of IS256 into agrC; in the second case, the altered RFLP pattern could be explained by a point mutation in a DraI restriction site. The third pattern could be assigned to agr group II with a point mutation resulting in an additional DraI site. The prevalence of agr group I-IV strains was examined in the different categories of individuals (table 1). No significant difference was observed in the distribution of the agr groups in isolates from patients with CF, compared with isolates from healthy control subjects ( , likelihood ratio test for con-P p .6 tingency tables). In these 2 categories, the predominant type was agr group I (51% and 41%, respectively). In contrast, in intubated patients and patients with chronic wounds, the majority of strains belonged to agr group II (47% and 62%, respectively). The agr group distribution in isolates from patients with chronic wounds differed significantly from those of healthy control subjects, even after a adjustment for multiple testing ( , likelihood ratio test for contingency tables). P p .0045 agr Interference groups in consecutive strains. We analyzed whether a resident S. aureus strain is replaced by a strain belonging to another agr interference group. For this evaluation, only those individuals who harbored different S. aureus genome types at consecutive samplings (1 interval) were included. Samples containing mixed S. aureus populationsverified by inspection of primary plates-were excluded. For patients with CF, 15 intervals (minimum length, 34 days; maximum length, 309 days) were available for analysis; for healthy individuals, 24 intervals (minimum length, 57 days; maximum length, 304 days) were available for analysis. Overall agr group distributions did not differ between the 2 samplings ( , P p .46 likelihood ratio test for contingency tables). In 27 (69%) of 39 intervals, consecutive strains belonged to interfering agr groups. Consecutive strains were assigned to different agr groups in 80% of the intervals in the patients with CF (12/15) and in 63% in healthy control subjects (15/24), which is not significantly different ( , Fisher's exact test). P p .30 We tested whether strain replacement in a carrier is congruent with random acquisition of S. aureus strains independent of its agr group. Our calculation was based on the frequencies of the 4 agr groups in patients with CF and healthy control subjects (table 1). The calculated probabilities of each agr group being randomly replaced with a strain from an interfering agr group was compared with the observed replacements (table 2). b Strain RNAIII negative during growth in vitro and no effect on the agr system of the cocolonizing strain(s). c Supernatant of agr group IV strains inhibited RNAIII expression in group I strains but not vice versa.
The observed changes agreed closely with a random acquisition of strains. agr Interference groups in cocolonizing strains. Specimens were analyzed for the simultaneous occurrence of different S. aureus strains by inspection of primary culture plates for phenotypically variant colonies. In most cases, variants belonged to the same genome type and were not analyzed any further in the present study. We found simultaneous isolates with dissimilar genome types in 3 tracheal secretions from intubated patients, in 1 wound swab from a patient with a wound, in 10 sputum specimens from patients with CF, and in 3 nose swabs from healthy individuals. In 10 of 17 cases, individuals were simultaneously colonized with strains belonging to different agr interference groups (table 3) . Cocolonization with multiple agr groups was observed in all categories of individuals. However, in the isolates from healthy individuals, a simultaneous occurrence of different agr groups was observed only once. In this case, the cocolonizing strains belonged to groups I and IV, for which interference in vitro is debated [13, 22] .
agr Activation or inhibition between cocolonizing strains in vitro. We examined whether cocolonizing strains belonging to interfering agr groups exhibit the proposed cross-inhibition of the agr system in vitro. Supernatants of cocolonizing strains were harvested in the postexponential phase and assayed for activation or inhibition of RNAIII transcription in the autologous and heterologous strains. After addition of the supernatants, strains were grown to early exponential (t1) and midexponential (t2) phase. Mutual cross-inhibition was observed in all strains belonging to agr groups I-III (table 3). The inhibitory effect was still detectable in midexponential growth phase (data not shown). Supernatant of strains belonging to agr group IV inhibited RNAIII transcription of group I strains but not vice versa (figure 1). However, inhibition was only visible in cells harvested in early exponential (t1) growth phase (group I strains; figure 1, lane 2) . In some strains, RNAIII synthesis already was detected during the early exponential growth phase, even without activation by the autologous supernatant. This was not limited to group IV strains, as described elsewhere [13] . There were also group IV strains which showed the typical late onset of RNAIII expression (i.e., group IV strain from person 18; figure 1). In 2 cases (subjects 7 and 10; table 3), one of the cocolonizing strains proved to be RNAIII neg- Figure 1 . Interference between different agr groups in vitro. For the assay, supernatants of cocolonizing strains were harvested in postexponential phase and assayed by Northern Blot analysis for activation or inhibition of RNAIII transcription in the autologous and heterologous strain. The intensity of the 23S and 16S rRNA bands stained by ethidium bromide was verified to be equivalent in all the samples before transfer. The figure shows 2 representative cocolonizing strain pairs from subjects 13 and 18, respectively. Left, Group I strain is tested with the supernatant from the group IV strains; right, group IV strain is tested with the supernatant from the group I strains. Autologous supernatant (lane 1), heterologous supernatant (lane 2), or culture broth (lane 3) was added after 30 min of growth, and bacteria were harvested in early exponential (t1) or midexponential (t2) growth phase.
ative, because no induction, even with its own supernatant, was seen. These strains consequently had no detectable effect on the agr system of the cocolonizing strain.
DISCUSSION
We analyzed whether intraspecies cross-inhibition of agr expression leads to the exclusion of heterologous strains at the site of colonization or infection. When we examined consecutive and cocolonizing isolates, we observed no strain interference during chronic lung infection in patients with CF. Despite regular antibiotic therapy, patients with CF are frequently colonized with S. aureus over several years, usually with the same strain [23, 24] . Occasionally, the patients become infected with additional strains, resulting in temporary cocolonization with у2 strains. Here, we were able to show that, in 80% of these cases, the incoming strain belonged to an interfering agr group. This ratio agrees closely with the calculated probability of becoming colonized with any strain prevalent in the community. More importantly, in 6 of 10 cases where 2 or 3 different strains could be isolated from a single sputum, the strains could be assigned to interfering agr groups. Nevertheless, these strains showed mutual cross-inhibition after in vitro subculturing. The lack of interference in vivo is consistent with our previous finding that the agr locus is not activated during chronic lung infection in CF [21] . In addition, Northern analysis of RNAIII revealed that at least 3 CF isolates were deficient in agr. The occurrence of agr mutants in patients with CF has been described elsewhere [21] . Thus, the data presented here further confirm our concept that agr plays no significant role in CF lung infection. One may even speculate that, for chronic nondisseminating infections, a loss of agr function may aid the pathogen to persist. The fact that down-regulation of agr is accompanied by up-regulation of proposed adherence factors is consistent with this hypothesis [25] . Thus, enhanced persistence may be achieved at the expense of reduced virulence. Accordingly, some prevalent MRSA strains [14] and glycolipid intermediate-level resistant S. aureus strains from device-related infection were shown to be deficient in agr [26] .
We also analyzed agr interference during S. aureus nose colonization in healthy individuals. In 63% of these cases, carriers became colonized with strains belonging to interfering agr groups. In a previous study, 2 cases of agr group change were detected in 5 cases of strain replacement in persistent S. aureus carriers [15] . Thus, in analyzing consecutive isolates, no direct proof for agr-dependent interference during nose colonization could be supplied. However, neither we nor van Leeuwen et al. [15] were able to rule out the possibility that the carriers were negative between samplings. In an earlier study [19] , we showed that the colonizing strain is spontaneously eradicated within 3 months in 13% of all nasal S. aureus carriers. Thus, strain replacement in the nose may take place without intermediate cocolonization. We extensively analyzed nose swabs (∼100 S. aureus -positive swabs) for the occurrence of у2 strains. In only 3 cases was a person simultaneously colonized with 2 different strains. Of interest, in 2 of these cases, the strains belonged to the same agr group. In 1 case, the strains belonged to agr groups I and IV, which were shown to be only partially inhibitory for each other. Thus, agr polymorphism may indeed contribute to the colonization dynamics of S. aureus in its major habitat, the nose.
Conflicting results have been published on the possible interference between agr group I and IV strains in vitro. Jarraud et al. [13] found a weak activation of agr in group I strains by spent culture supernatants from group IV strains. More recently, that group showed that synthetic group IV AIP activates AgrC I [27] . However, in our system, supernatants derived from group IV strains clearly inhibited the agr system of group I strains in early growth. This result is consistent with the findings of McDowell et al. [22] , who showed that a synthetic group IV AIP is an inhibitor of the agr response of all other groups. The same authors also reported inhibition of group IV strains by a synthetic group I AIP. However, we and others [13] could show that supernatant from group I strains had no effect on group IV strains. Thus, the results concerning the interaction between group IV and group I strains are conflicting. One major difference between the publications is the genetic background in which agr activity was measured: agr-null strains were used by Jarraud et al. [13] and Lyon et al. [27] , the agr-positive strain RN6390 was used by McDowell et al. [22] , and clinical, agr-positive strains were used by us. In addition, the growth phase in which the interaction between strains from interfering agr groups is determined has an impact on the result. For instance, in our assay, the inhibition of group I strains by supernatant from group IV strains was visible only when harvesting the cells in early exponential phase.
To estimate the probability of becoming colonized with a strain from a certain agr group, we determined the distribution of group I-IV strains in several categories of individuals: patients with CF, healthy individuals, intubated patients, and patients with chronic wounds. Of interest, the distribution of agr groups in the strains from patients with CF and healthy control subjects was very similar. This result supports our previous findings that infecting strains from patients with CF do not differ from the general S. aureus population present in the community [19] . In this strain collection, 41% of the isolates belonged to agr group I. Group I showed additional agr polymorphisms, but this variants displayed no mutual cross-inhibition (data not shown). Subgroup Ia was already described by Papakyriacou et al. [14] , who also concluded, on the basis of sequence analysis, that groups I and Ia belong to the same interference group. Thus far, only one recent publication [18] described agr group distribution in S. aureus populations from the community. In this study, a similar occurrence (37%) of group I strains was described. In other strain collections, group I strains also were the most prevalent [16, 17] , representing up to 92% of all strains [15] . agr group IV strains are usually rare, with the exception of strains from exfoliative toxin-mediated diseases [16] .
Of interest, we found a different distribution of agr groups in intubated patients and patients with chronic wounds than in the community at large. In these categories of patients, the agr group II strains were those isolated most frequently. The significant different distribution of agr groups in isolates from patients with chronic wounds, especially the high prevalence of group II strains, is particularly surprising. However, because a predominant PFGE type was isolated from these patients, a common source has to be considered. The wounds swabs were isolated from out-patients with chronic wounds, such as patients with diabetis mellitus who regularly attended the same consultation clinic.
